Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Weight-loss outcomes vary based on your starting point, consistency, and overall health
8.2 Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al
Browse all Peptides & GLP-1 education Independent editorial review
Front Endocrinol 12:645617
US$ 28.09
US$ 21.33
US$ 22.25
